Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Active Ingredient: Laronidase 0.58mg/mL
Dosage Form: Concentrate for infusion
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: BioMarin Pharmaceutical Inc, Novato, California, United States of America
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 9th day of January 2009.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).